Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Gynecologic Cancers
NCI-CCC Breast Tumor Board Question
Questions discussed in this category
Would you consider HRT after BSO in a pre-menopausal gBRCA2+ patient who has no intention of ever having prophylactic bilateral mastectomies and who declines chemoprophylaxis?
2 Answers available
8498
Papers discussed in this category
Obstet Gynecol,
Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
JAMA,
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Cancer Prev Res (Phila), 2019 Aug 16
Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.
Related Topics in Gynecologic Cancers
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers
Melanoma/Skin Cancer